Oral Squamous Cell Carcinoma (OSCC) Recruiting Phase 2 / 3 Trials for Docetaxel (DB01248)

Back to Oral Squamous Cell Carcinoma (OSCC)

Also known as: Squamous Cell Carcinoma of the Oral Cavity / Oral Cavity Squamous Cell Carcinoma / Squamous Cell Cancer of the Oral Cavity / Squamous Cell Carcinoma (SCC) of the Oral Cavity / Oral Squamous Cell Carcinoma / Squamous Cell Carcinoma Mouth / Squamous Cell Carcinoma (SCC) of the Mouth / Squamous Cell Carcinoma of Mouth / Squamous Cell Carcinoma of the Oral / Squamous cell carcinoma of mouth (disorder)

Indication	Status	Phase
DBCOND0087451 (Oral Squamous Cell Carcinoma (OSCC))	Recruiting	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05125055	Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC	Treatment	Albumin human (DB00062) Cisplatin (DB00515) Docetaxel (DB01248) Fluorouracil (DB00544) Paclitaxel (DB01229) Toripalimab (DB15043)